肝细胞癌免疫相关lncRNA预后风险模型的建立与评估
作者:
通讯作者:
作者单位:

1.中南大学湘雅医学院附属株洲医院,感染内科,湖南 株洲 412007;2.中南大学湘雅医学院附属株洲医院,血液科,湖南 株洲 412007

作者简介:

彭双,中南大学湘雅医学院附属株洲医院主治医师,主要从事慢性乙肝、肝肿瘤方面的研究。

基金项目:

湖南省自然科学基金资助项目(2017JJ3532)。


Construction of a prognostic immune-related lncrna risk model for hepatocellular carcinoma and its validation
Author:
Affiliation:

1.Department of Infectious Medicine, the Affiliated Zhuzhou Hospital, Xiangya Medical College, Central South University, Zhuzhou, Hunan 412007, China;2.Department of Hematology, the Affiliated Zhuzhou Hospital, Xiangya Medical College, Central South University, Zhuzhou, Hunan 412007, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    背景与目的 肝细胞癌(HCC)目前是全球肿瘤死亡的主要原因之一,越来越多的证据表明,长非编码RNA(lncRNA)可以作为肿瘤预后的生物标志物。然而,lncRNA与HCC生存预后的关系仍未阐明。本研究筛选HCC预后免疫相关lncRNA,并构建预后风险模型。方法 从癌症基因组图谱(TCGA)中下载HCC转录组数据和临床资料,提取免疫相关lncRNA,单因素Cox回归分析筛选预后免疫相关lncRNA,进一步纳入多因素Cox回归分析。根据最优AIC值确定lncRNA建立预后风险模型,计算患者的风险评分,根据中位风险值将患者分为低分险组和高风险组,采用Kaplan-Meier法对两组患者进行生存分析并绘制生存曲线,通过绘制ROC曲线对预后风险模型进行效能评估。用单因素和多因素Cox回归分析患者临床病理资料和风险评分与总生存率的关系,探索HCC预后危险因素。结果 在HCC中共提取到免疫相关lncRNA 143个(Cor>0.6,P<0.001),通过单因素Cox回归分析筛选出17个预后免疫相关lncRNA,纳入多因素Cox回归分析得到8个免疫相关lncRNA(AL139384.1、MAPKAPK5-AS1、LINC02362、SLC25A30-AS1、DANCR、AC124798.1、LINC02499和AC023157.3)用于建立预后风险模型。低风险组患者生存率明显高于高风险组患者(P<0.05),预后风险模型ROC曲线下面积为0.774,多因素Cox回归分析显示患者风险评分为HCC患者预后的独立影响因子(HR=1.608,95% CI=1.351~1.913,P<0.001)。结论 基于8个免疫相关lncRNA建立预后风险模型可以有效的预测HCC患者的生存预后,风险评分为HCC独立的预后因素。

    Abstract:

    Background and Aims Hepatocellular carcinoma (HCC) is currently responsible for one of the leading causes of cancer death worldwide. Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) can be used as biomarkers of tumor prognosis. However, the relationship between lncRNAs and the survival prognosis of HCC remains unclear. This study was conducted to screen the immune-related lncRNAs associated with the prognosis of HCC, and then construct a prognostic risk model.Methods The transcriptome data and clinical data of HCC were obtained from the Cancer Genome Atlas (TCGA), and the immune-related lncRNAs were extracted. The prognostic immune-related lncRNAs were screened by univariate Cox regression analysis, and were further incorporated into multivariate Cox regression analysis. A prognostic risk model was established using the lncRNAs determined by the optimal AIC value, by which the patient's risk scores were calculated. The patients were divided into low-risk group and high-risk group according to the median risk value. Survival analysis of the two groups of patients was performed and their survival curves were drawn by Kaplan-Meier method. The efficiency of the prognostic risk model was assessed by drawing ROC curve. The associations of clinicopathologic variables and risk score with the overall survival of the patients were determined by univariate and multivariate Cox regression analysis.Results A total of 143 immune-related lncRNAs were extracted from HCC (Cor>0.6, P<0.001). Seventeen prognostic immune-prognostic-related lncRNAs were screened by univariate Cox regression analysis, and 8 of them (AL139384.1, MAPKAPK5-AS1, LINC02362, SLC25A30-AS1, DANCR, AC124798.1, LINC02499 and AC023157.3) were obtained after incorporation into multivariate Cox regression analysis to establish a prognostic risk model. The survival rate of patients in low-risk group was significantly higher than that of patients in high-risk group (P<0.05). The area under the ROC curve of the prognostic risk model was 0.774, and the multivariate Cox regression analysis showed that the risk score was an independent factor influencing the prognosis of HCC patients (HR=1.608, 95% CI=1.351-1.913, P<0.001).Conclusion The establishment of prognostic risk model based on 8 immune-related lncRNAs can effectively predict the survival prognosis of HCC patients, and the risk score is an independent prognostic factor for HCC.

    表 3 多因素Cox回归分析筛选免疫相关lncRNA构建HCC预后风险模型Table 3 Construction of HCC prognostic risk model using the immune-related lncRNAs screened by multivariate Cox regression analysis
    图1 HCC免疫相关lncRNA预后风险模型分析 A:风险评分划分低风险组和高风险组;B:HCC患者风险评分和生存时间及生存状态;C:8个免疫相关lncRNA基因热图Fig.1 Analysis of the immune-related lncRNA prognostic risk model of HCC A: Division of low-risk group and high-risk group according to the risk score; B: HCC patient risk score and survival time and survival status; C: Gene heat map of the 8 immune-related lncRNAs
    图2 低风险组和高风险组HCC患者的生存曲线Fig.2 Survival curves of the HCC patients in low-risk group and high-risk group
    图3 预后风险模型ROC曲线Fig.3 ROC curve of prognostic risk model
    图4 预后风险模型Cox回归分析森林图 A:单因素分析;B:多因素分析Fig.4 Forest plot of Cox regression analysis of prognostic risk model A: Univariate analysis; B: Multivariate analysis
    表 2 单因素Cox回归分析筛选HCC预后免疫相关lncRNATable 2 HCC Prognostic immune-related lncRNAs screened by univariate Cox regression analysis
    表 1 225例HCC患者临床病理特征[n(%)]Table 1 Clinicopathologic characteristics of 225 patients with HCC [n (%)]
    参考文献
    相似文献
    引证文献
引用本文

彭双,谭英征,杨秋红,易来.肝细胞癌免疫相关lncRNA预后风险模型的建立与评估[J].中国普通外科杂志,2022,31(1):64-71.
DOI:10.7659/j. issn.1005-6947.2022.01.007

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2021-01-08
  • 最后修改日期:2021-07-20
  • 录用日期:
  • 在线发布日期: 2022-01-27